Steven M. Haffner
Department of Medicine and Clinical Epidemiology
University of Texas Health Science Center
San Antonio
Texas 78240
USA
Name/email consistency: high
- Abdominal adiposity and cardiometabolic risk: do we have all the answers? Haffner, S.M. Am. J. Med. (2007)
- Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Haffner, S.M. Obesity. (Silver. Spring) (2006)
- The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Haffner, S.M. Am. J. Cardiol. (2006)
- Diabetes and the metabolic syndrome--when is it best to intervene to prevent?. Haffner, S. Atheroscler. Suppl (2006)
- Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns. Haffner, S.M. Am. J. Med. (2006)
- Rationale for new American Diabetes Association Guidelines: are national cholesterol education program goals adequate for the patient with diabetes mellitus?. Haffner, S. Am. J. Cardiol. (2005)
- Statin therapy for the treatment of diabetic dyslipidemia. Haffner, S.M. Diabetes Metab. Res. Rev. (2003)
- Pre-diabetes, insulin resistance, inflammation and CVD risk. Haffner, S.M. Diabetes Res. Clin. Pract. (2003)
- Insulin resistance, inflammation, and the prediabetic state. Haffner, S.M. Am. J. Cardiol. (2003)
- Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?. Haffner, S.M., D'Agostino, R., Festa, A., Bergman, R.N., Mykkänen, L., Karter, A., Saad, M.F., Wagenknecht, L.E. Diabetes. Care (2003)
- Epidemic obesity and the metabolic syndrome. Haffner, S., Taegtmeyer, H. Circulation (2003)
- Metabolic syndrome - a new risk factor of coronary heart disease?. Haffner, S., Cassells, H.B. Diabetes. Obes. Metab (2003)
- Glucose-tolerance testing in acute myocardial infarction. Haffner, S.M. Lancet (2002)
- Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Haffner, S.M., Greenberg, A.S., Weston, W.M., Chen, H., Williams, K., Freed, M.I. Circulation (2002)
- Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. Haffner, S.M. Am. J. Cardiol. (2002)
- Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Haffner, S.M., Mykkänen, L., Festa, A., Burke, J.P., Stern, M.P. Circulation (2000)
- Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study). Haffner, S.M., Agostino, R.D., Saad, M.F., O'Leary, D.H., Savage, P.J., Rewers, M., Selby, J., Bergman, R.N., Mykkänen, L. Am. J. Cardiol. (2000)
- Obesity and the metabolic syndrome: the San Antonio Heart Study. Haffner, S.M. Br. J. Nutr. (2000)
- Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men?. Haffner, S.M., Mykkänen, L., Rainwater, D.L., Karhapää, P., Laakso, M. Obes. Res. (1999)
- Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. Haffner, S.M., Alexander, C.M., Cook, T.J., Boccuzzi, S.J., Musliner, T.A., Pedersen, T.R., Kjekshus, J., Pyörälä, K. Arch. Intern. Med. (1999)
